Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Agenus Inc.

NASDAQ: AGENHealthcare / Biotechnology / USA
3.61+0.0700+1.98%Vol 1 302 9621Y Perf -13.78%
Feb 15th, 2019 16:00
BID3.61 ASK3.62
Open3.56 Previous Close3.54
Pre-Market3.58 After-Trading3.67
 0.04 1.13%  0.06 1.66%
Target Price
7.00 
Analyst Rating
Strong Buy 1.00
Potencial %
93.91 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★ —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)433 
Earnings Rating
Sell
Price Range Ratio 52wk %
44.52 
Earnings Date
21st Mar 2019

Today's Price Range

3.503.69

 

52wk Range

1.546.19

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
13.17%
3 Months
71.09%
6 Months
112.35%
1 Year
-13.78%
3 Years
19.93%
5 Years
20.33%

Quotes

Name / TickerPriceChg.Chg.%
AGEN3.610.07001.98
AAPL170.42-0.3800-0.22
GOOG1 113.65-8.0200-0.72
MSFT108.221.32001.23
XOM77.711.44001.89
WFC49.220.70001.44
JNJ136.382.07001.54
FB162.50-1.4500-0.88
GE10.090.05000.50
JPM105.553.13003.06
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.90
Current Ratio
1.20
Long Term Debt to Total Capital
-
Total Debt to Equity
-
Interest Coverage
-
Leverage Ratio -1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-303.90
EBITDA Margin
-287.90
Pre-tax Profit Margin
-422.10
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
49.72
PS Ratios
15.08
Price to Cash Flow
116.70
Price to Free Cash Flow
-4.70
Cash Flow Per Share
-1.14
Price to Tangible Book
-2.75
Book Value per Share
-0.99
Enterprise Value (in ths.)
424 594
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-64 461.20
ROE last 12 Months
161.73
Return on Assets (5Y Avg)
-58.93
ROA last 12 Months
-105.22
Return on Capital (5Y Avg)
-
ROC last 12 Months
-
Return on invested Capital Q
-
Return on invested Capital Y
-
Assets Turnover
0.10
Receivables Turnover
3.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
30 333
Revenue per Share
0.23
Revenue Growth 3 Years
12.89
Revenue Growth 5 Years
64.85
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.25-0.29-16.00
Q02 2018-0.38-0.2436.84
Q01 2018-0.28-0.42-50.00
Q04 2017-0.28-0.35-25.00
Q03 2017-0.37-0.370.00
Q02 2017-0.36-0.3211.11
Q01 2017-0.32-0.1843.75
Q04 2016-0.33-0.309.09
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.280.00-
12/2018 FY-1.35-11.57Negative
3/2019 QR-0.330.00-
12/2019 FY-1.44-2.86Negative
Next Report Date21st Mar 2019
Estimated EPS Next Report-0.28
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume1 302 962
Shares Outstanding (in ths.)119 996
Trades Count3 567
Dollar Volume4 576 440
Avg. Volume1 922 443
Avg. Weekly Volume957 975
Avg. Monthly Volume1 494 429
Avg. Quarterly Volume1 992 900

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

36%64%

Bearish Bullish

69%31%

Bearish Bullish

45%55%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News